These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 37006130)

  • 21. ESMO International Consortium Study on the availability, out-of-pocket costs and accessibility of antineoplastic medicines in countries outside of Europe.
    Cherny NI; Sullivan R; Torode J; Saar M; Eniu A
    Ann Oncol; 2017 Nov; 28(11):2633-2647. PubMed ID: 28950323
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modernizing the World Health Organization List of Essential Medicines for Preventing and Controlling Cardiovascular Diseases.
    Kishore SP; Blank E; Heller DJ; Patel A; Peters A; Price M; Vidula M; Fuster V; Onuma O; Huffman MD; Vedanthan R
    J Am Coll Cardiol; 2018 Feb; 71(5):564-574. PubMed ID: 29406862
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Availability of Essential Medicines for Pediatric Oncology in Armenia.
    Simonyan T; Papyan R; Danielyan S; Sargsyan L; Grigoryan V; Topchyan H; Azaryan A; Tananyan A; Muradyan A; Tamamyan G
    Asian Pac J Cancer Prev; 2019 Apr; 20(4):991-994. PubMed ID: 31030465
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Access to Cardiovascular Disease and Hypertension Medicines in Developing Countries: An Analysis of Essential Medicine Lists, Price, Availability, and Affordability.
    Husain MJ; Datta BK; Kostova D; Joseph KT; Asma S; Richter P; Jaffe MG; Kishore SP
    J Am Heart Assoc; 2020 May; 9(9):e015302. PubMed ID: 32338557
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Determinants of access to childhood cancer medicines: a comparative, mixed-methods analysis of four Caribbean countries.
    Boateng R; Petricca K; Tang B; Parikh S; SinQuee-Brown C; Alexis C; Browne-Farmer C; Reece-Mills M; Salmon SM; Bodkyn C; Gupta S; Maguire B; Denburg AE
    Lancet Glob Health; 2021 Sep; 9(9):e1314-e1324. PubMed ID: 34416215
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cancer Medicines: What Is Essential and Affordable in India?
    Sengar M; Fundytus A; Hopman W; Pramesh CS; Radhakrishnan V; Ganesan P; Mathew A; Lombe D; Jalink M; Gyawali B; Trapani D; Roitberg F; De Vries EGE; Moja L; Ilbawi A; Sullivan R; Booth CM
    JCO Glob Oncol; 2022 Jul; 8():e2200060. PubMed ID: 35853192
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of evidence supporting the Federation of Bosnia and Herzegovina reimbursement medicines lists: role of the WHO Essential Medicines List, Cochrane systematic reviews and technology assessment reports.
    Mahmić-Kaknjo M; Marušić A
    Eur J Clin Pharmacol; 2015 Jul; 71(7):825-33. PubMed ID: 25956715
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Essential medicines for emergency care in Africa.
    Broccoli MC; Pigoga JL; Nyirenda M; Wallis L; Calvello Hynes EJ
    Emerg Med J; 2018 Jul; 35(7):412-419. PubMed ID: 29627770
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Registration and local production of essential medicines in Uganda.
    Brhlikova P; Maigetter K; Murison J; Agaba AG; Tusiimire J; Pollock AM
    J Pharm Policy Pract; 2020; 13():31. PubMed ID: 32793355
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Availability of cytotoxic medicines in the WHO essential medicine list used in treating childhood malignancies in low-income and lower-middle-income countries: a systematic review protocol.
    Seneviwickrama M; Gunasekera S; Liyanage G; Heiyanthuduwa W; Jayakody S
    BMJ Open; 2023 Jun; 13(6):e071988. PubMed ID: 37336532
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Access to and Affordability of World Health Organization Essential Medicines for Cancer in Sub-Saharan Africa: Examples from Kenya, Rwanda, and Uganda.
    Kizub DA; Naik S; Abogan AA; Pain D; Sammut S; Shulman LN; Martei YM
    Oncologist; 2022 Nov; 27(11):958-970. PubMed ID: 36094141
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Using the WHO essential medicines list to assess the appropriateness of insurance coverage decisions: a case study of the Croatian national medicine reimbursement list.
    Jeličić Kadić A; Žanić M; Škaričić N; Marušić A
    PLoS One; 2014; 9(10):e111474. PubMed ID: 25337860
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Audit of essential medicine listing and registration status of medicines on standard treatment guidelines in Kenya, Tanzania and Uganda: Case study of malaria, tuberculosis, hypertension and type 2 diabetes mellitus.
    Babatunde D; Pollock AM; Ocan M; Brhlikova P
    JRSM Open; 2024 Mar; 15(3):20542704241232814. PubMed ID: 38560365
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Availability, Price and Affordability of Anticancer Medicines: Evidence from Two Cross-Sectional Surveys in the Jiangsu Province, China.
    Zhu Y; Wang Y; Sun X; Li X
    Int J Environ Res Public Health; 2019 Oct; 16(19):. PubMed ID: 31623326
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of National Drug Pricing Policy 2018 on access to medicines in Lahore division, Pakistan: a pre-post survey study using WHO/HAI methodology.
    Saeed A; Saeed H; Saleem Z; Yang C; Jiang M; Zhao M; Ji W; Aziz MM; Khan FU; Gillani AH; Atif N; Fang Y; Babar ZUD
    BMJ Open; 2020 Oct; 10(10):e034720. PubMed ID: 33033079
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Accessibility of essential anticancer medicines for children in the Sichuan Province of China.
    Chen Z; Li S; Zou K; Li H; Zeng L; Lu X; Jia ZJ; Cheng G; Zhang L
    Front Public Health; 2022; 10():980969. PubMed ID: 36408013
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Essential Medicines at the National Level: The Global Asthma Network's Essential Asthma Medicines Survey 2014.
    Bissell K; Ellwood P; Ellwood E; Chiang CY; Marks GB; El Sony A; Asher I; Billo N; Perrin C;
    Int J Environ Res Public Health; 2019 Feb; 16(4):. PubMed ID: 30791442
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantitative evaluation of essential medicines lists: the South African case study.
    Perumal-Pillay VA; Suleman F
    BMC Health Serv Res; 2016 Dec; 16(1):687. PubMed ID: 27955710
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selection of WHO-recommended essential medicines for non-communicable diseases on National Essential Medicines Lists.
    Jarvis JD; Woods H; Bali A; Oronsaye E; Persaud N
    PLoS One; 2019; 14(8):e0220781. PubMed ID: 31398195
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A pilot study on the rational use of medicines in four tertiary care hospitals through validated World Health Organization prescribing drugs indicators.
    Khan Z; Ahmed N; Zafar S; Ullah Khan F; Ur Rehman A; Parreiras Martins MA; Karataş Y
    Ann Ig; 2020; 32(4):368-375. PubMed ID: 32744295
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.